LDH or NSE or LDH and NSE as pretreatment prognostic factors in small cell lung cancer?: A commentary
- 31 October 2000
- journal article
- editorial
- Published by Elsevier in Lung Cancer
- Vol. 30 (1) , 51-53
- https://doi.org/10.1016/s0169-5002(00)00155-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapyLung Cancer, 2000
- Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete RemissionNew England Journal of Medicine, 1999
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999
- Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancerEuropean Journal Of Cancer, 1993
- Tumour markers for prediction of survival and monitoring of remission in small cell lung cancerBritish Journal of Cancer, 1993
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?British Journal of Cancer, 1990
- The prognostic influence of serum neuron specific enolase in small cell lung cancerBritish Journal of Cancer, 1988
- Prognostic factors in small cell lung cancer: A simple prognostic index is better than conventional stagingEuropean Journal of Cancer and Clinical Oncology, 1987
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987